MedTrace Logo

African-American Heart Failure Trial

NCT00047775 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 1100

Last updated 2005-06-24

No results posted yet for this study

Summary

A placebo-controlled trial of BiDil added to standard therapy in African-American patients with heart failure.

Conditions

  • Congestive Heart Failure

Interventions

DRUG

BiDil

Sponsors & Collaborators

  • Nitromed

    lead INDUSTRY

Principal Investigators

  • Anne L. Taylor, M.D. · University of Minnesota

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-05-31
Completion
2004-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00047775 on ClinicalTrials.gov